New Benefits of Hydroxychloroquine in Pregnant Women with Systemic Lupus Erythematosus: A Retrospective Study in a Tertiary Centre
Abstract Objective: To determine pregnancy outcomes in women with systemic lupus erythematosus (SLE) who were treated with hydroxychloroquine in a tertiary center. Methods: A retrospective study involving pregnant women with SLE who had antenatal follow-up and delivery in between 1 January 2007 and 1 January 2017. All participants were retrospectively enrolled and categorized into two groups based on hydroxychloroquine treatment during pregnancy. Results: There were 82 pregnancies included with 47 (57.3%) in the hydroxychloroquine group and 35 (42.7%) in the non-hydroxychloroquine group. Amongst hydroxychloroquine users, there were significantly more pregnancies with musculoskeletal involvement (p = 0.03), heavier mean neonatal birthweight (p = 0.02), and prolonged duration of pregnancy (p = 0.001). In non-hydroxychloroquine patients, there were significantly more recurrent miscarriages (p = 0.003), incidence of hypertension (p = 0.01) and gestational diabetes mellitus (p = 0.01) and concurrent medical illness (p = 0.005). Hydroxychloroquine use during pregnancy was protective against hypertension (p = 0.001), and the gestational age at delivery had significant effect on the neonatal birthweight (p = 0.001). However, duration of the disease had a significant negative effect on the neonatal birthweight (p = 0.016). Conclusion: Hydroxychloroquine enhanced better neonatal outcomes and reduced adverse pregnancy outcomes and antenatal complications such as hypertension and diabetes..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
|---|---|
| Enthalten in: |
Revista Brasileira de Ginecologia e Obstetrícia - 42(2020), 11, Seite 705-711 |
| Sprache: |
Englisch ; Portugiesisch |
|---|
| Beteiligte Personen: |
Rahana Abd Rahman [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Gynecology and obstetrics |
|---|
| doi: |
10.1055/s-0040-1715140 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ074431439 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ074431439 | ||
| 003 | DE-627 | ||
| 005 | 20230503112848.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230228s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1055/s-0040-1715140 |2 doi | |
| 035 | |a (DE-627)DOAJ074431439 | ||
| 035 | |a (DE-599)DOAJb5e66277908049599f89adaeac66b998 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a por | ||
| 050 | 0 | |a RG1-991 | |
| 100 | 0 | |a Rahana Abd Rahman |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a New Benefits of Hydroxychloroquine in Pregnant Women with Systemic Lupus Erythematosus: A Retrospective Study in a Tertiary Centre |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Objective: To determine pregnancy outcomes in women with systemic lupus erythematosus (SLE) who were treated with hydroxychloroquine in a tertiary center. Methods: A retrospective study involving pregnant women with SLE who had antenatal follow-up and delivery in between 1 January 2007 and 1 January 2017. All participants were retrospectively enrolled and categorized into two groups based on hydroxychloroquine treatment during pregnancy. Results: There were 82 pregnancies included with 47 (57.3%) in the hydroxychloroquine group and 35 (42.7%) in the non-hydroxychloroquine group. Amongst hydroxychloroquine users, there were significantly more pregnancies with musculoskeletal involvement (p = 0.03), heavier mean neonatal birthweight (p = 0.02), and prolonged duration of pregnancy (p = 0.001). In non-hydroxychloroquine patients, there were significantly more recurrent miscarriages (p = 0.003), incidence of hypertension (p = 0.01) and gestational diabetes mellitus (p = 0.01) and concurrent medical illness (p = 0.005). Hydroxychloroquine use during pregnancy was protective against hypertension (p = 0.001), and the gestational age at delivery had significant effect on the neonatal birthweight (p = 0.001). However, duration of the disease had a significant negative effect on the neonatal birthweight (p = 0.016). Conclusion: Hydroxychloroquine enhanced better neonatal outcomes and reduced adverse pregnancy outcomes and antenatal complications such as hypertension and diabetes. | ||
| 650 | 4 | |a hydroxychloroquine | |
| 650 | 4 | |a systemic lupus erythematosus | |
| 650 | 4 | |a pregnancy | |
| 653 | 0 | |a Gynecology and obstetrics | |
| 700 | 0 | |a Kyaw Min Tun |e verfasserin |4 aut | |
| 700 | 0 | |a Ixora Kamisan Atan |e verfasserin |4 aut | |
| 700 | 0 | |a Mohd Shahrir Mohamed Said |e verfasserin |4 aut | |
| 700 | 0 | |a Ruslinda Mustafar |e verfasserin |4 aut | |
| 700 | 0 | |a Ani Amelia Zainuddin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Revista Brasileira de Ginecologia e Obstetrícia |d Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, 2004 |g 42(2020), 11, Seite 705-711 |w (DE-627)DOAJ000091820 |x 01007203 |7 nnns |
| 773 | 1 | 8 | |g volume:42 |g year:2020 |g number:11 |g pages:705-711 |
| 856 | 4 | 0 | |u https://doi.org/10.1055/s-0040-1715140 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/b5e66277908049599f89adaeac66b998 |z kostenfrei |
| 856 | 4 | 0 | |u http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032020001100705&tlng=en |z kostenfrei |
| 856 | 4 | 0 | |u http://www.scielo.br/pdf/rbgo/v42n11/1806-9339-rbgo-42-11-705.pdf |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/0100-7203 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 42 |j 2020 |e 11 |h 705-711 | ||